3179 results for «600»
3179 results
TAVI outcomes - Part 2
21 Nov 2023 – From PCR London Valves 2023
Explore the latest insights in TAVI outcomes with this session: delve into the pursuit of transatlantic harmonization in echocardiography core laboratory analysis and adjudication according to VARC3 guidelines, investigate the nuances of TAV deployment within an elliptical aortic root, uncover the clinical impact of multiple resheathing...
Leaflet modification techniques
20 Nov 2023 – From PCR London Valves 2023
Discover cutting-edge leaflet modification approaches in transcatheter interventions with this selection of cases: explore the imaging aspects of the emerging ShortCut procedure for coronary protection in Valve-in-Valve TAVR, experience the effectiveness and simplicity of Balloon - Basilica for valve-in-valve interventions, learn about the adaptability of right...
TAVI in challenging aortic anatomy
20 Nov 2023 – From PCR London Valves 2023
Explore TAVI in challenging aortic anatomy through this selection of cases: navigate strategies for crossing severely adverse calcific bicuspid aortic valves in horizontal aortas, witness TAVI adaptability in cases of severe aortic stenosis with situs inversus totalis, learn about the complexities of TAVI implantation in patients...
TAVI - New indications, techniques and devices - Part 2
20 Nov 2023 – From PCR London Valves 2023
Consult this session for a swift overview of evolving TAVI indications and techniques: gain insights into thirty-day outcomes with Evolut FX, stratified by heart team risk, witness the 12-month follow-up of the Valvosoft first-in-man study, uncover sizing considerations in bicuspid tapered aortic valves undergoing TAVI from the...
Mitral TEER - Part 2
21 Nov 2023 – From PCR London Valves 2023
Explore compelling cases in this session: delve into the role of medical therapy post-TEER for managing secondary mitral regurgitation with right ventricular dysfunction, examine the impact of right ventricular parameters following TMV repair and witness the art of a safe bailout strategy after single leaflet detachment...
Valve in valve - TAV in TAV - Part 2
21 Nov 2023 – From PCR London Valves 2023
Join us for this session, where complex cases shed light on the evolving landscape of valve-in-valve interventions: delve into the efficacy of THV-in-THV for addressing supra-skirtal leakage accompanied by intravascular hemolysis, learn more about the challenges of TAVI-in-TAVI with the deployment of SAPIEN3 Ultra in a...
Treatment of paravalvular leak
21 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in paravalvular leak management with this selection of cases: discover the unique strategy of employing three plugs to close a challenging mitral paravalvular leak, navigate the challenges of tackling device migration and retrieval in the closure of a sizable aortic paravalvular leak, gain...
TAVI - Coronary complications
21 Nov 2023 – From PCR London Valves 2023
Explore challenging situations in this session: witness the rare occurrence of coronary embolization resulting from a fractured biological surgical valve in an aortic valve-in-valve procedure, uncover the complexities surrounding the late presentation of cardiogenic shock after TAVR, navigate the unusual challenge of intermittent left main obstruction caused...
Mitral valve interventions in challenging clinical situations
21 Nov 2023 – From PCR London Valves 2023
Discover innovative approaches to mitral valve interventions in challenging clinical situations: navigate the challenges of critical stenosis in a bioprosthetic mitral valve, learn more about the use of iVAC-2L in transcatheter edge-to-edge repair for a mitral valve lacking leaflet coaptation, explore mitral transcutaneous edge-to-edge repair guided by transthoracic...
Aortic regurgitation - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to gain valuable knowledge on approaches to address aortic regurgitation: uncover the clinical effectiveness of TAVR in managing aortic insufficiency associated with LVAD and delve into the comparison between echocardiography and magnetic resonance imaging for assessing device regurgitation in patients undergoing TAVI.
TAVI - Coronary access
21 Nov 2023 – From PCR London Valves 2023
Delve into the complexities of TAVI and coronary access with this session: explore the use of IVUS in assessing coronary arteries at high risk for obstruction following valve-in-valve TAVI, witness the application of patient-specific computer simulation to predict coronary re-access post-TAVI in bicuspid anatomy, navigate the...
Rare complications of structural intervention
21 Nov 2023 – From PCR London Valves 2023
Join us in this session for a look at rare and challenging scenarios in structural interventions: delve into the complexities of an ascending aorta mycotic aneurysm in a patient with a prior TAVI procedure, witness a unique case showcasing a misloaded self-expanding TAVR device, uncover the...
Prevention and treatment of left ventricular outflow tract obstruction
19 Nov 2023 – From PCR London Valves 2023
Explore intriguing cases in this session and gain a deeper understanding of preventing and managing LVOT obstruction: uncover innovative approaches such as Valve-in-Valve TMVR with Lampoon, learn about the nuances of TMVR after re-section of the anterior leaflet, and more!
Transcatheter mitral repair and replacement for primary mitral regurgitation - LIVE case
19 Nov 2023 – From PCR London Valves 2023
This session aims to highlight the remarkable advancements achieved in transcatheter mitral valve intervention over the past two decades, since its inception. Follow two TEER cases which illustrate this rapidly growing field:
- Transcatheter edge-edge mitral valve repair
A 77-year-old male with a history of SAVR (bioprothesis) + LIM-LAD/Diag, normal...
Key questions in mitral valve intervention - What do I need to know about imaging?
19 Nov 2023 – From PCR London Valves 2023
Explore the crucial aspects of imaging in mitral valve intervention with a focus on the entire treatment pathway, from patient selection to post-procedural follow-up. Gain insights into optimizing patient selection for mitral valve edge-to-edge repair and replacement, and learn key views essential for optimal imaging and...
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
27 Oct 2023
Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...
Author
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
COVID-19 vaccines: Burning questions from the community and real-world applicability
13 Jan 2021
View a number of questions of interest to the interventional cardiovascular community, as well as the real-world applicability of COVID-19 vaccine trials.
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)